BAT Kenya stock faces new nicotine pouch ban threat
Published on 11/09/2026 at 00:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSNew regulatory risk for BAT Kenya
- A Kenyan bill would prohibit the manufacture, sale, advertising and distribution of nicotine pouches.
- The proposal threatens BAT Kenya's diversification strategy after the company resumed Velo sales and reported stronger oral nicotine demand.
- Management is also facing pressure from illicit cigarette trade and is calling for tougher enforcement and greater regulatory certainty.
British American Tobacco Kenya faces a fresh regulatory risk after a Kenyan bill proposed banning nicotine pouches. Business Daily reported on Sunday, November 8, 2026, that the Alcoholic Drinks and Drugs Control Laws (Amendment) Bill, 2026, would prohibit the manufacture, sale, use, advertising, promotion and distribution of nicotine pouches.
Velo strategy meets legislative risk
The proposal is significant for BAT Kenya because the company resumed sales of its Velo oral nicotine product after regulatory changes allowed a relaunch in the first half of 2025. Management had expected nicotine pouches to reach one-fifth of annual sales over the medium term as the business shifted away from traditional cigarettes.
The bill is awaiting committee scrutiny. If enacted in its current form, it could limit a growth channel that helped offset weaker domestic cigarette sales in the first half of 2026. Chief executive Sidney Wafula called for regulatory certainty and said the company was still assessing the rationale for the proposal.
Illicit trade adds operating pressure
BAT Kenya's diversification push is taking place alongside pressure from illicit cigarette sales. The company told Business Daily that half-year oral nicotine sales helped offset weaker domestic demand caused by illicit trade. The report said BAT Kenya also collected excise duty and value-added tax on behalf of the government, while management called for stronger enforcement and border controls.
For investors, the proposed ban raises a direct question about whether Velo can become a meaningful growth driver in Kenya. The outcome will depend on the bill's committee review, the government's wider tobacco-control framework and the final rules governing oral nicotine products.
BAT Kenya stock is covered in the BAT Kenya stock real-time quote section.
Kenyan equities are covered with current market reports.
BAT Kenya's business and rivals
British American Tobacco Kenya plc is part of the international British American Tobacco Group and sells tobacco and nicotine products in Kenya. Its portfolio includes conventional cigarettes and Velo nicotine pouches, while the company is seeking to expand beyond combustible products. In Kenya's nicotine pouch market, it competes with Philip Morris International's Zyn as well as products from Consumer Brands International and Dholakia Tobacco. BAT Kenya is an established local tobacco producer, but its diversification plans remain more exposed to domestic regulation than the group's broader international operations.
BAT Kenya at a glance
- Company: British American Tobacco Kenya plc
- ISIN: KE0000000075
- Exchange: Nairobi Securities Exchange
- Latest reported period: Six months to June 2026
- Net revenue: KSh 12.2 billion, up 4.6 percent
- Net profit: KSh 3.08 billion, up 3.1 percent
- Interim dividend: KSh 10 per share
More news and analyses on BAT Kenya stock.
